Conference on Pharmaceutical Pricing Practices, Utilization, and Costs

08/08/2000

Conference on Pharmaceutical Pricing Practices, Utilization, and Costs

August 8th & 9th

Meeting Summary

Agenda

Dr. Margarget A. Hamburg's Opening Remarks

List of Partipants

Projections of Drug Approvals, Patent Expirations, and Generic Entry from 2000 to 2004 by C. Daniel Mullins, Ph.D., Francis Palumbo, Ph.D., J.D., & Bruce Stuart, Ph.D. -- FINAL

Factors Driving Pharmaceutical Expenditures: An Overview by Ernst R. Berndt, Ph.D. -- FINAL

Explaining the Growth in Prescription Drug Spending: A Review of Recent Studies by Mark Merlis, M.A. -- FINAL

Prescription Drug Coverage, Spending, Utilization and Prices by Jack Hoadley, Ph.D.

Pharmaceutical Pricing: Practices & Issues by Robert A. Freeman, Ph.D. -- FINAL

Pricing Mechanisms Used by the Federal Government to Contain Prescription Drug Costs by Anna Cook, Ph.D. -- FINAL

Drug Utilization Trends by Therapeutic Class by Cindy Parks Thomas, Ph.D. and Grant Ritter, Ph.D. -- FINAL

Medicare Beneficiaries: Prescription Drug Utilization Trends by John Poisal -- FINAL

Medication Decisions-Right and Wrong by Bruce Stuart, Ph.D. and Becky Briesacher, M.A. -- FINAL

FDA's Research About Consumer-Directed Prescription Drug Program by Nancy M. Ostrove, Ph.D. -- FINAL

Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager PBM Efforts, Effects, and Implication by David H. Kreling, Ph.D., R.Ph. -- FINAL

Role of Price Transparency in the Pharmaceutical Market by Stephen W. Schondelmeyer, Pharm.D., Ph.D. -- FINAL

Managing the Unmanageable: Drug Payment and Utilization Management Strategies in Physician Organizations by Helene Levens Lipton, Ph.D. -- FINAL

Price Trends for Prescription Pharmaceuticals: 1995-1999 by Joseph A. DiMasi, Ph.D. -- FINAL

Why Different Purchasers Pay Different Prices for Prescription Drugs by Anna Cook -- FINAL